Sun Pharma Advanced Research Company Ltd - Financial Result for the Quarter ended 30th Sep'26
Sun Pharma Advanced Research Company Ltd · Outcome · 03 Nov 2026, 1:16 am
Sun Pharma Advanced Research Company Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 3,003 (+282.1% YoY | -24.8% QoQ) ■ EBITDA: -4,561 (+30.6% YoY | -34.1% QoQ) ■ EBITDA Margin (%): -152 (+68425 bps YoY | -6671 bps QoQ) ■ PAT: -2,439 (+67.8% YoY | -17.4% QoQ) ■ EPS (INR): -0.75 (+67.9% YoY | -17.2% QoQ)
Original exchange filing (PDF)
More announcements from Sun Pharma Advanced Research Company Ltd
- Receipt of No- Objection Letters from the Stock Exchanges for Reclassification of Promoter Group · 12 Nov 2026
- Response of Clarification sought from BSE Limited · 11 Nov 2026
- The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on November 11, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. · 11 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 · 03 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Sun Pharma Advanced Research Company Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 02 Nov 2026
- To consider and approve the financial results for the quarter and half year ended September 30, 2026 · 02 Nov 2026
- Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited .... · 02 Nov 2026
